Back to top

Analyst Blog

Zacks Equity Research

Dow Chemical Joins Bend Research

DD DOW

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

U.S. chemical giant Dow Chemical (DOW - Analyst Report) has joined forces with leading pharmaceutical drug-delivery research company, Bend Research Inc., to offer drug-solubility solutions and new polymers. The terms of the deal were not disclosed.

Bend Research specializes in the development and commercialization of pharmaceutical technologies. Its leading drug development and delivery technologies include spray-dried dispersion (SDD), controlled-release, inhalation and biotherapeutics technologies.

Under the collaboration, the companies will develop and market SDD solutions which address technology gap in drug manufacturing and delivery. Moreover, they will deliver new polymers having the ability to tailor materials to meet the performance needs of specific drugs. Dow will offer hypromellose and hypromellose acetate succinate to tailor these materials and next-generation cellulosic and noncellulosic polymers for improved performance.

The partnership will bring together Dow’s excipient and materials science expertise, high-throughput synthesis and commercial scale-up capabilities with Bend Research’s SDD screening, formulation, scale-up and technology-transfer capabilities. The collaboration will mitigate drug-development risk by integrating materials development and optimization early in the formulation development process for SDDs to attain optimal clinical results.

Headquartered in Michigan, Dow Chemical is one of the largest chemical manufacturers in the world, offering a range of chemical, plastic and agricultural products and services. It competes with EI DuPont de Nemours & Co. (DD - Analyst Report) among others.

Dow is benefiting from strong fundamentals in agriculture and food markets. The company retains its strategy of growth through joint ventures and acquisitions. A string of innovative products in its pipeline also adds to its strength.

Dow is targeting faster-growing geographies. The company earns two-thirds of its income from outside the U.S. Growth in emerging economies has been especially fast, contributing a meaningful portion of the company’s sales.

However, Dow is contending with soft electronics and construction end-markets and is facing challenges in Western Europe due to the prevailing recessionary conditions.

Dow currently retains a short-term Zacks #3 Rank (Hold). We have a long-term Underperform recommendation on the stock.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%